Travere Therapeutics
TVTX
#4846
Rank
NZ$2.37 B
Marketcap
$26.81
Share price
-9.48%
Change (1 day)
131.02%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -$7.41

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$8.08. In 2022 the company made an earnings per share (EPS) of -$7.82 a decrease over its 2021 EPS that were of -$5.42.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.41-5.21%
2022-$7.8244.22%
2021-$5.42-10.09%
2020-$6.03-2.6%
2019-$6.1936.22%
2018-$4.5464.94%
2017-$2.7520.31%
2016-$2.29-135.46%
2015$6.46-175.68%
2014-$8.5398.75%
2013-$4.291746.15%
2012-$0.231.34%
2011-$0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.79-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA